The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1.
about
Modeling of neutral solute transport in a dynamically loaded porous permeable gel: implications for articular cartilage biosynthesis and tissue engineering.Regulation of insulin-like growth factor II receptors by growth hormone and insulin in rat adipocytes.Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor IStructure, evolution, expression and regulation of insulin-like growth factors I and II.Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.Somatomedins: chemical and functional characteristics of the different molecular forms.The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation.Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiationDetermination of IGF-II levels in human serum using the erythroleukemia cell line K562.Mitogenically uncoupled insulin and IGF-I receptors of differentiated human neuroblastoma cells are functional and mediate ligand-induced signals.The insulin-like effect of growth hormone on insulin-like growth factor II receptors is opposed by cyclic AMP. Evidence for a common post-receptor pathway for growth hormone and insulin actionPreferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes.Somatomedin-C levels in treated and untreated patients with acromegaly.Growth hormone and somatomedin serum levels in patients with major depressive illness undergoing electroconvulsive therapy.Degradation of somatomedins by the thioredoxin system.
P2860
Q33786909-FCA04F6A-98FF-4424-8413-C9AD17760B22Q34626658-F311A434-FBD8-4326-865C-7CB8F3B68C7BQ35615447-3EBA86B1-F548-4749-B5DC-4E860EDDBAFCQ36922028-9DEF15FF-5708-4695-B489-61834E5FE0ECQ36993997-D89F4432-6F51-400A-9793-44F1440467E2Q38279963-23CF82FD-2D39-4E57-A0FD-BA44F8EA8474Q40492402-44766F02-F6F5-4175-86CC-57A1E8784FEEQ41505363-DB749112-0B13-4565-9A39-F7FE97AE9AC5Q41744741-C2A375B9-BC93-455D-8ACD-1B665025F461Q41752959-3580B674-50FC-42B5-8ADB-04060A17F847Q42480066-376D93DB-8028-4725-82E2-D55640681C03Q42855371-5AB23753-5C0E-4516-93F2-B6BC11F5AC0BQ43592801-FCDA434C-BD31-4A18-989F-5B4D25228AADQ51630562-88A9F531-2DF7-4503-B90D-97DBDE668BB6Q51808038-353F6CE6-838E-4535-8E90-F696B6EAC49EQ54798888-F73A51CB-9D31-4519-9A42-82A4E6410896
P2860
The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
The characterization of somato ...... insulin-like growth factor 1.
@en
The characterization of somato ...... insulin-like growth factor 1.
@nl
type
label
The characterization of somato ...... insulin-like growth factor 1.
@en
The characterization of somato ...... insulin-like growth factor 1.
@nl
prefLabel
The characterization of somato ...... insulin-like growth factor 1.
@en
The characterization of somato ...... insulin-like growth factor 1.
@nl
P2093
P1433
P1476
The characterization of somato ...... insulin-like growth factor 1.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1984.TB08349.X
P407
P577
1984-08-01T00:00:00Z